The Louisiana State University Health Sciences Center New Orleans is a public university focused on the health sciences and located in New Orleans, Louisiana. It is part of the LSU System and is the home of six schools, 12 Centers of Excellence, and two patient care clinics.

During the past decade, MBCCOP - LSU Health Sciences Center conducted 141 clinical trials. In the 10-year time frame, 141 clinical trials started and 124 clinical trials were completed, i.e. on average, 87.9% percent of trials that started reached the finish line to date. In the past 5 years, 56 clinical trials started and 62 clinical trials were completed. i.e. 110.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MBCCOP - LSU Health Sciences Center" #1 sponsor was "SWOG Cancer Research Network" with 106 trials, followed by "National Cancer Institute (NCI)" with 67 trials sponsored, "Radiation Therapy Oncology Group" with 44 trials sponsored, "Alliance for Clinical Trials in Oncology" with 34 trials sponsored and "Eastern Cooperative Oncology Group" with 34 trials sponsored. Other sponsors include 188 different institutions and companies that sponsored additional 90 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MBCCOP - LSU Health Sciences Center" #1 collaborator was "National Cancer Institute (NCI)" with 294 trials as a collaborator, "SWOG Cancer Research Network" with 21 trials as a collaborator, "Eastern Cooperative Oncology Group" with 17 trials as a collaborator, "Cancer and Leukemia Group B" with 16 trials as a collaborator and "NRG Oncology" with 14 trials as a collaborator. Other collaborators include 161 different institutions and companies that were collaborators in the rest 107 trials.

According to Clinical.Site data, the most researched conditions in "MBCCOP - LSU Health Sciences Center" are "Leukemia" (31 trials), "Breast Cancer" (28 trials), "Lung Cancer" (28 trials), "Head and Neck Cancer" (24 trials) and "Lymphoma" (21 trials). Many other conditions were trialed in "MBCCOP - LSU Health Sciences Center" in a lesser frequency.

Most popular intervention types in "MBCCOP - LSU Health Sciences Center" are "Drug" (360 trials), "Biological" (120 trials), "Other" (112 trials), "Radiation" (101 trials) and "Procedure" (85 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (63 trials), "Laboratory Biomarker Analysis" (43 trials), "cyclophosphamide" (37 trials), "cisplatin" (33 trials) and "Placebo" (32 trials). Other intervention names were less common.

The vast majority of trials in "MBCCOP - LSU Health Sciences Center" are 391 trials for "All" genders, 61 trials for "Female" genders and 24 trials for "Male" genders.

Currently, there are NaN active trials in "MBCCOP - LSU Health Sciences Center". undefined are not yet recruiting, 53 are recruiting, 70 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 302 completed trials in MBCCOP - LSU Health Sciences Center, 3 suspended trials, and 37 terminated clinical trials to date.

Out of the total trials that were conducted in MBCCOP - LSU Health Sciences Center, 23 "Phase 1" clinical trials were conducted, 184 "Phase 2" clinical trials and 216 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 27 trials that are defined as “Not Applicable".

MBCCOP - LSU Health Sciences Center has several departments that took part in Clinical trials: "Stanley S. Scott Cancer Center at Louisiana State University Medical Center - New Orleans" - 6 trials, "Children's Hospital of New Orleans/LSUHSC" - 5 trials, "LSU School of Dentistry" - 2 trials, "Louisiana Cardiovascular Research Ctr" - 2 trials, "LSU Eye Center" - 2 trials, "LSU Health Sciences Center, Department of Neurosurgery" - 2 trials, "Louisiana State University Epilepsy Center of Excellence" - 2 trials, "Louisiana State University Health Sciences Center, The Ernest N. Morial Asthma, Allergy and Respiratory Disease Center" - 2 trials